MEDARTIS HOLDING AG |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 80.2 CHF | -0.99% |
|
-0.99% | -4.52% |
| 04-04 | Global markets live: Novo Nordisk, Ocado, Walt Disney, Apple, Tesla... |  |
| 04-04 | Medartis Issues CFH116 Million Convertible Bonds | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 513.5 | 547.7 | 1,538 | 972.2 | 1,038 | 1,087 | - | - |
| Enterprise Value (EV) 1 | 440.4 | 492.1 | 1,480 | 979.6 | 1,064 | 1,110 | 1,106 | 1,086 |
| P/E ratio | - | -581 x | 224 x | -167 x | 1,680 x | 114 x | 68.3 x | 46.9 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 3.95 x | 4.39 x | 9.62 x | 5.32 x | 4.9 x | 4.46 x | 3.78 x | 3.21 x |
| EV / Revenue | 3.38 x | 3.95 x | 9.25 x | 5.36 x | 5.02 x | 4.55 x | 3.85 x | 3.2 x |
| EV / EBITDA | 22 x | 25 x | 54 x | 60.5 x | 31.7 x | 27.7 x | 22.2 x | 17.5 x |
| EV / FCF | - | 234 x | 114 x | -50.6 x | 211 x | 294 x | 83.8 x | - |
| FCF Yield | - | 0.43% | 0.88% | -1.98% | 0.47% | 0.34% | 1.19% | - |
| Price to Book | 2.38 x | 2.57 x | 6.87 x | 4.09 x | 4.07 x | 3.6 x | 3.42 x | 3.17 x |
| Nbr of stocks (in thousands) | 11,751 | 11,778 | 11,814 | 11,857 | 12,359 | 13,559 | - | - |
| Reference price 2 | 43.70 | 46.50 | 130.2 | 82.00 | 84.00 | 80.20 | 80.20 | 80.20 |
| Announcement Date | 20-03-03 | 21-03-10 | 22-03-07 | 23-03-14 | 24-03-12 | - | - | - |
1CHF in Million2CHF
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 130.1 | 124.7 | 159.9 | 182.8 | 212 | 244 | 287.4 | 339.1 |
| EBITDA 1 | 20 | 19.7 | 27.4 | 16.2 | 33.6 | 40.09 | 49.72 | 61.88 |
| EBIT 1 | 7 | 3.8 | 11.06 | -1.922 | 9.104 | 16.45 | 23.85 | 32.31 |
| Operating Margin | 5.38% | 3.05% | 6.92% | -1.05% | 4.29% | 6.74% | 8.3% | 9.53% |
| Earnings before Tax (EBT) 1 | 3.319 | -3.264 | 8.29 | -7.145 | 1.794 | 9.504 | 19.21 | 27.5 |
| Net income 1 | 2.147 | -0.9436 | 6.838 | -5.783 | 0.619 | 8.751 | 14.63 | 21.54 |
| Net margin | 1.65% | -0.76% | 4.28% | -3.16% | 0.29% | 3.59% | 5.09% | 6.35% |
| EPS 2 | - | -0.0800 | 0.5800 | -0.4900 | 0.0500 | 0.7027 | 1.175 | 1.709 |
| Free Cash Flow 1 | - | 2.102 | 12.97 | -19.36 | 5.046 | 3.78 | 13.2 | - |
| FCF margin | - | 1.69% | 8.11% | -10.59% | 2.38% | 1.55% | 4.59% | - |
| FCF Conversion (EBITDA) | - | 10.67% | 47.34% | - | 15.02% | 9.43% | 26.55% | - |
| FCF Conversion (Net income) | - | - | 189.7% | - | 815.19% | 43.19% | 90.22% | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Announcement Date | 20-03-03 | 21-03-10 | 22-03-07 | 23-03-14 | 24-03-12 | - | - | - |
1CHF in Million2CHF
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 S1 | 2021 S2 | 2022 S1 | 2023 S1 | 2023 S2 |
|---|---|---|---|---|---|
| Net sales 1 | 73.6 | 86.31 | 88.38 | 103.3 | 108.8 |
| EBITDA 1 | 14.1 | 13.3 | 9.9 | 13.1 | 18.8 |
| EBIT | 6.3 | 4.798 | 1.3 | 2.8 | - |
| Operating Margin | 8.56% | 5.56% | 1.47% | 2.71% | - |
| Earnings before Tax (EBT) 1 | - | - | - | - | 1.649 |
| Net income 1 | 7.1 | -0.2449 | 0.00377 | -0.8 | 1.467 |
| Net margin | 9.65% | -0.28% | 0% | -0.77% | 1.35% |
| EPS | 0.6000 | -0.0200 | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 21-08-17 | 22-03-07 | 22-08-16 | 23-08-15 | 24-03-12 |
1CHF in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | 7.35 | 25.4 | 22.7 | 18.4 | - |
| Net Cash position 1 | 73.1 | 55.6 | 58.6 | - | - | - | - | 1.71 |
| Leverage (Debt/EBITDA) | - | - | - | 0.4537 x | 0.7547 x | 0.5672 x | 0.3709 x | - |
| Free Cash Flow 1 | - | 2.1 | 13 | -19.4 | 5.05 | 3.78 | 13.2 | - |
| ROE (net income / shareholders' equity) | - | -0.44% | 3.13% | - | 0.25% | 3.72% | 4.97% | 7.01% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share 2 | 18.40 | 18.10 | 19.00 | 20.10 | 20.60 | 22.30 | 23.50 | 25.30 |
| Cash Flow per Share 2 | - | 1.070 | 1.780 | -0.3300 | 1.630 | 2.650 | 2.430 | 2.810 |
| Capex 1 | - | 10.5 | 8.02 | 15.4 | 14.9 | 18.9 | 19.8 | 15.8 |
| Capex / Sales | - | 8.43% | 5.02% | 8.44% | 7.04% | 7.73% | 6.88% | 4.66% |
| Announcement Date | 20-03-03 | 21-03-10 | 22-03-07 | 23-03-14 | 24-03-12 | - | - | - |
1CHF in Million2CHF
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
80.2
CHF
Average target price
98.98
CHF
Spread / Average Target
+23.41%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -4.52% | 1.19B | |
| +12.37% | 128B | |
| -6.82% | 10.69B | |
| +2.17% | 8.93B | |
| +18.79% | 7.32B | |
| +20.77% | 4.82B | |
| +6.97% | 3.4B | |
| -1.41% | 3.03B | |
| -5.07% | 2.23B | |
| -4.22% | 2.13B |
- Stock Market
- Equities
- MED Stock
- Financials Medartis Holding AG
